Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ANXA2 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
mRNA | UPF3B | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
mRNA | TRIM13 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | MDC1 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | PRPF40A | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
mRNA | C19orf48 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | SRF | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | TIGD6 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | LATS1 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
mRNA | FSD1 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |